ARTICLE | Clinical News
Raxone idebenone regulatory update
September 14, 2015 7:00 AM UTC
The European Commission approved an MAA from Santhera for Raxone idebenone to treat visual impairment in adolescent and adults with Leber’s hereditary optic neuropathy (LHON). This year, Santhera plan...